ABIVAX Société Anonyme (LON: 0RA9)
London
· Delayed Price · Currency is GBP · Price in EUR 6.13
-0.03 (-0.49%)
Jan 23, 2025, 1:41 PM BST
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of 332.18 million as of January 23, 2025. Its market cap has decreased by -38.30% in one year.
Market Cap
332.18M
Enterprise Value
240.04M
Revenue
7.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.13
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from 143.21M to 332.18M, an increase of 131.96%. That is a compound annual growth rate of 9.18%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.37B |
| GSK plc | 55.25B |
| Haleon | 33.81B |
| Smith & Nephew | 8.96B |
| ConvaTec Group | 4.94B |
| Hikma Pharmaceuticals | 4.62B |
| HUTCHMED (China) | 1.99B |
| Oxford Nanopore Technologies | 1.42B |